Advertisement

Meningococcal Serogroup B Vaccine Policies and Recommendations at U.S. Colleges and Universities

      Serogroup B meningococcal (MenB) disease is a rare but serious illness that can result in permanent disability and death. In the U.S., where approximately 50–60 cases and 5–10 deaths among adolescents and young adults are reported annually, 2 MenB vaccines are approved for people aged 10–25 years and recommended by the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention for select populations at high risk due to immune deficiencies, potential occupational exposure, or an ongoing outbreak.
      • MacNeil JR
      • Rubin L
      • Folaranmi T
      • Ortega-Sanchez IR
      • Patel M
      • Martin SW
      Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015.
      ,
      • Patton ME
      • Stephens D
      • Moore K
      • MacNeil JR
      Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine - Advisory Committee on Immunization Practices, 2016.
      For adolescents and young adults aged 16–23 years, MenB vaccination is not routinely recommended but deferred to patients and healthcare providers on the basis of shared clinical decision making.
      Centers for Disease Control and Prevention
      Advisory Committee on Immunization Practices (ACIP): ACIP shared clinical decision-making recommendations.
      This guidance differs from the ACIP recommendation for the meningococcal conjugate vaccine, which is recommended for all adolescents for protection against serogroups A, C, W, and Y.
      • Cohn AC
      • MacNeil JR
      • Clark TA
      • et al.
      Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
      Colleges and universities, the sites of numerous recent MenB cases and outbreaks, are well-positioned to support educational efforts about the disease and its prevention and to promote vaccine use through recommendations or requirements.
      • Soeters HM
      • McNamara LA
      • Blain AE
      • et al.
      University-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013-2018.
      ,

      Oliver SE, Patton ME, Hoban M, et al. Evaluation of meningococcal vaccination policies among colleges and universities - United States, 2017. J Am Coll Health. In press. Online November 11, 2019. https://doi.org/10.1080/07448481.2019.1687484.

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • MacNeil JR
        • Rubin L
        • Folaranmi T
        • Ortega-Sanchez IR
        • Patel M
        • Martin SW
        Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the Advisory Committee on Immunization Practices, 2015.
        MMWR Morb Mortal Wkly Rep. 2015; 64: 1171-1176
        • Patton ME
        • Stephens D
        • Moore K
        • MacNeil JR
        Updated recommendations for use of MenB-FHbp serogroup B meningococcal vaccine - Advisory Committee on Immunization Practices, 2016.
        MMWR Morb Mortal Wkly Rep. 2017; 66: 509-513
        • Centers for Disease Control and Prevention
        Advisory Committee on Immunization Practices (ACIP): ACIP shared clinical decision-making recommendations.
        February 10, 2020 (Updated)
        • Cohn AC
        • MacNeil JR
        • Clark TA
        • et al.
        Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2013; 62: 1-22
        • Soeters HM
        • McNamara LA
        • Blain AE
        • et al.
        University-based outbreaks of meningococcal disease caused by serogroup B, United States, 2013-2018.
        Emerg Infect Dis. 2019; 25: 434-440
      1. Oliver SE, Patton ME, Hoban M, et al. Evaluation of meningococcal vaccination policies among colleges and universities - United States, 2017. J Am Coll Health. In press. Online November 11, 2019. https://doi.org/10.1080/07448481.2019.1687484.

      2. The Carnegie classifications for institutions of higher education. https://carnegieclassifications.iu.edu/. Accessed May 7, 2020.

        • Walker TY
        • Elam-Evans LD
        • Yankey D
        • et al.
        National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2018.
        MMWR Morb Mortal Wkly Rep. 2019; 68: 718-723